One treatment strategy in ccRCC is to inhibit the VEGF signaling that is commonly dysregulated following VHL gene inactivation within RCC tumor cells and would otherwise stimulate endothelial cell growth and angiogenesis6. The gene discussed is VEGFA; the disease is neoplasm.